Clyde Biosciences Cardiomyocyte Assay
1 known investors
Find your way into Clyde Biosciences Cardiomyocyte Assay
Clyde Biosciences is a contract research organization offering predictive cardiac safety and efficacy testing using human iPSC-derived cardiomyocyte models, aimed at pharmaceutical and biotech teams assessing cardiotoxicity for clinical translation. It provides functional cardiac safety data aligned with regulatory guidance, including the CiPA Assay.
Founders & leadership
GS
Godfrey SmithChief Scientific Officer and Co-Founder
FB
Francis BurtonHead of Software and Modeling & Co-Founder
RH
Richard HendersonChief Executive Officer
MB
Mark BryantChief Business Officer
Investors · 1
Competitors · 2
by search overlapMolecular Devices4 shared keywordsMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
Agilent3 shared keywordsAgilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors. The company operates through three segments: Life Sciences and Diagnostics Markets (which includes contract manufacturing services for oligonucleotide therapeutics and pathology solutions), Agilent CrossLab (providing lab services and automation), and Applied Markets (offering analytical instruments and software).
Companies competing with Clyde Biosciences Cardiomyocyte Assay for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Clyde Biosciences Cardiomyocyte Assay do?
- Clyde Biosciences is a contract research organization offering predictive cardiac safety and efficacy testing using human iPSC-derived cardiomyocyte models, aimed at pharmaceutical and biotech teams assessing cardiotoxicity for clinical translation. It provides functional cardiac safety data aligned with regulatory guidance, including the CiPA Assay.
- Who founded Clyde Biosciences Cardiomyocyte Assay?
- Clyde Biosciences Cardiomyocyte Assay was founded by Godfrey Smith, Francis Burton.
- Who are Clyde Biosciences Cardiomyocyte Assay's investors?
- Clyde Biosciences Cardiomyocyte Assay's investors include Epidarex Capital.